Titlebook: Cancer Therapy; Monoclonal Antibodie Hans G. Beger (Professor of Surgery),Markus Büchle Conference proceedings 1989 Springer-Verlag Berlin

Denial

書目名稱Cancer Therapy影響因子(影響力)




書目名稱Cancer Therapy影響因子(影響力)學(xué)科排名




書目名稱Cancer Therapy網(wǎng)絡(luò)公開度




書目名稱Cancer Therapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cancer Therapy被引頻次




書目名稱Cancer Therapy被引頻次學(xué)科排名




書目名稱Cancer Therapy年度引用




書目名稱Cancer Therapy年度引用學(xué)科排名




書目名稱Cancer Therapy讀者反饋




書目名稱Cancer Therapy讀者反饋學(xué)科排名

無聊點好

larder

https://doi.org/10.1007/978-981-19-5570-9lonal antibodies has rapidly led to clinical investigations. Experience with monoclonal antibodies in the treatment of patients with melanoma is limited [4, 9, 10, 12, 13, 17, 19] because only small groups of patients have been treated so far. According to these studies, treatment with ganglioside antibodies appears most promising.

NOMAD

Munificent

Figate

Mab 17-1A Used for Therapy of Patients with Metastatic Colorectal Carcinomasially on fetal cells. On normal mature cells, TAA might be detected only by highly sensitive techniques or after manipulation of the cell membrane. On malignant cells, TAA are often re-expressed in high concentrations. Such antigens can be exploited not only for diagnostic purposes, but also as targets for immunotherapy.

Figate

Immunotherapy of Malignant Melanomaslonal antibodies has rapidly led to clinical investigations. Experience with monoclonal antibodies in the treatment of patients with melanoma is limited [4, 9, 10, 12, 13, 17, 19] because only small groups of patients have been treated so far. According to these studies, treatment with ganglioside antibodies appears most promising.

坦白

The Role of Interferon in the Management of Patients with Hairy Cell Leukemia and Multiple Myeloma of cancer, particularly since in 1981 highly purified material produced by recombinant DNA technology has become available in addition to natural IFNs [25, 51, 59]. So far, the most impressive clinical results have been achieved in hematologic disorders, especially in hairy cell leukemia [26, 41, 54].

terazosin

crease